These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23341125)
1. Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3 T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer? Uematsu T; Kasami M; Watanabe J Breast Cancer; 2014 Nov; 21(6):684-92. PubMed ID: 23341125 [TBL] [Abstract][Full Text] [Related]
2. Preoperative MRI features associated with lymphovascular invasion in node-negative invasive breast cancer: A propensity-matched analysis. Cheon H; Kim HJ; Lee SM; Cho SH; Shin KM; Kim GC; Park JY; Kim WH J Magn Reson Imaging; 2017 Oct; 46(4):1037-1044. PubMed ID: 28370761 [TBL] [Abstract][Full Text] [Related]
3. Can T2-weighted 3-T breast MRI predict clinically occult inflammatory breast cancer before pathological examination? A single-center experience. Uematsu T; Kasami M; Watanabe J Breast Cancer; 2014 Jan; 21(1):115-21. PubMed ID: 23104394 [TBL] [Abstract][Full Text] [Related]
4. Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer? Harada TL; Uematsu T; Nakashima K; Sugino T; Nishimura S; Takahashi K; Hayashi T; Tadokoro Y; Watanabe J; Nakamoto S; Ito T Eur Radiol; 2020 Jun; 30(6):3363-3370. PubMed ID: 32062698 [TBL] [Abstract][Full Text] [Related]
5. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer. Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236 [TBL] [Abstract][Full Text] [Related]
6. High Peritumoral and Intratumoral T2 Signal Intensity in HER2-Positive Breast Cancers on Preneoadjuvant Breast MRI: Assessment of Associations With Histopathologic Characteristics. Jirarayapong J; Portnow LH; Chikarmane SA; Lan Z; Gombos EC AJR Am J Roentgenol; 2024 Mar; 222(3):e2330280. PubMed ID: 38117101 [No Abstract] [Full Text] [Related]
7. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers? Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946 [TBL] [Abstract][Full Text] [Related]
8. MRI characteristics of breast edema for assessing axillary lymph node burden in early-stage breast cancer: a retrospective bicentric study. Xu Z; Ding Y; Zhao K; Han C; Shi Z; Cui Y; Liu C; Lin H; Pan X; Li P; Chen M; Wang H; Deng X; Liang C; Xie Y; Liu Z Eur Radiol; 2022 Dec; 32(12):8213-8225. PubMed ID: 35704112 [TBL] [Abstract][Full Text] [Related]
9. Is "prepectoral edema" a morphologic sign for malignant breast tumors? Kaiser CG; Herold M; Baltzer PA; Dietzel M; Krammer J; Gajda M; Camara O; Schoenberg SO; Kaiser WA; Wasser K Acad Radiol; 2015 Jun; 22(6):684-9. PubMed ID: 25784323 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of "Prepectoral Edema" in MR-mammography. Kaiser CG; Herold M; Krammer J; Baltzer P; Gajda M; Camara O; Schoenberg S; Kaiser WA; Dietzel M Anticancer Res; 2017 Apr; 37(4):1989-1995. PubMed ID: 28373472 [TBL] [Abstract][Full Text] [Related]
11. Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast. Kerslake RW; Carleton PJ; Fox JN; Imrie MJ; Cook AM; Read JR; Bowsley SJ; Buckley DL; Horsman A Clin Radiol; 1995 Jul; 50(7):440-54. PubMed ID: 7614789 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study. Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy. Harada TL; Uematsu T; Nakashima K; Kawabata T; Nishimura S; Takahashi K; Tadokoro Y; Hayashi T; Tsuchiya K; Watanabe J; Sugino T Radiology; 2021 Apr; 299(1):53-62. PubMed ID: 33560188 [TBL] [Abstract][Full Text] [Related]
14. Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema. Uematsu T Breast Cancer; 2015 Jan; 22(1):66-70. PubMed ID: 25336185 [TBL] [Abstract][Full Text] [Related]
15. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
16. Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner. Panzironi G; Moffa G; Galati F; Marzocca F; Rizzo V; Pediconi F Breast Cancer Res Treat; 2020 May; 181(1):53-60. PubMed ID: 32185587 [TBL] [Abstract][Full Text] [Related]
17. Detectability and clinicohistological characteristics of small (≤1 cm) invasive breast cancer. Yoo EY; Shin JH; Ko EY; Han BK; Cho EY; Nam SJ; Hahn SY; Ko ES Eur J Radiol; 2013 Oct; 82(10):e556-61. PubMed ID: 23830035 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results. Luciani A; Dao TH; Lapeyre M; Schwarzinger M; Debaecque C; Lantieri L; Revelon G; Bouanane M; Kobeiter H; Rahmouni A AJR Am J Roentgenol; 2004 Apr; 182(4):1059-67. PubMed ID: 15039188 [TBL] [Abstract][Full Text] [Related]
19. Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer. Ko ES; Han BK; Kim RB; Ko EY; Shin JH; Hahn SY; Nam SJ; Lee JE; Lee SK; Im YH; Park YH Ann Surg Oncol; 2013 Aug; 20(8):2562-8. PubMed ID: 23463090 [TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced MRI kinetics of invasive breast cancer: a potential prognostic marker for radiation therapy. Loiselle CR; Eby PR; DeMartini WB; Peacock S; Bittner N; Lehman CD; Kim JN Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1314-9. PubMed ID: 19604652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]